Skip to main content
SpringerLink
Log in

Gene Regulatory Mechanisms Governing Energy Metabolism during Cardiac Hypertrophic Growth

  • Published:
Heart Failure Reviews Aims and scope Submit manuscript

Abstract

Studies in a variety of mammalian species, including humans, have demonstrated a reduction in fatty acid oxidation (FAO) and increased glucose utilization in pathologic cardiac hypertrophy, consistent with reinduction of the fetal energy metabolic program. This review describes results of recent molecular studies aimed at delineating the gene regulatory events which facilitate myocardial energy substrate switches during hypertrophic growth of the heart. Studies aimed at the characterization of transcriptional control mechanisms governing FAO enzyme gene expression in the cardiac myocyte have defined a central role for the fatty acid-activated nuclear receptor peroxisome proliferator-activated receptor α (PPARα). Cardiac FAO enzyme gene expression was shown to be coordinately downregulated in murine models of ventricular pressure overload, consistent with the energy substrate switch away from fatty acid utilization in the hypertrophied heart. Nuclear protein levels of PPARα decline in the ventricle in response to pressure overload, while several Sp and nuclear receptor transcription factors are induced to fetal levels, consistent with their binding to DNA as transcriptional repressors of rate-limiting FAO enzyme genes with hypertrophy. Knowledge of key components of this transcriptional regulatory pathway will allow for the development of genetic engineering strategies in mice that will modulate fatty acid oxidative flux and assist in defining whether energy metabolic derangements play a primary role in the development of pathologic cardiac hypertrophy and eventual progression to heart failure.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Lompre AM, Schwartz K, Albis A, Lacombe B, Thiem NV, Swyngedauw B. Myosin isozymes redistribution in chronic heart overloading. Nature 1979;282:105–107.

    Google Scholar 

  2. Nadal-Ginard B, Mahdavi V. Molecular basis of cardiac performance. Plasticity of the myocardium generated through protein isoform switches. J Clin Invest 1989;84:1694–1700.

    Google Scholar 

  3. Lattion AL, Michel JB, Arnauld E, Corvol P, Soubrier F. Myocardial recruitment during ANF mRNA increase with volume overload in the rat. Am J Physiol 1986;251:H890–H896.

    Google Scholar 

  4. Buttrick PM, Kaplan M, Leinwand LA, Scheuer J. Alterations in gene expression in the rat heart after chronic pathological and physiological loads. J Mol Cell Cardiol 1994;26:61–67.

    Google Scholar 

  5. Schwartz K, Boheler K, de la Bastie D, Lompre AM, Mercadier JJ. Switches in cardiac muscle gene expression as a result of pressure and volume overload. Am J Physiol 1992;262:R364–R369.

    Google Scholar 

  6. Nagai R, Zarain-Herzberg A, Brandl C, Fuji J, Tada M, MacLennan DH, Alpert N, Periasamy M. Regulation of myocardial Ca2+-ATPase and phospholamban mRNA expression in response to pressure overload and thyroid hormone. Proc Natl Acad Sci USA 1989;86:2966–2970.

    Google Scholar 

  7. de la Bastie D, Levitsky D, Rappaport L, Mercadier JJ, Marotte F, Wisnewsky C, Brovkovich V, Schwartz K, Lompre AM. Function of the sarcoplasmic reticulum and expression of its Ca2(+)-ATPase gene in pressure overload-induced cardiac hypertrophy in the rat. Circ Res 1990;66:554–564.

    Google Scholar 

  8. Feldman AM, Weinberg EO, Ray PE, Lorell BH. Selective changes in cardiac gene expression during compensated hypertrophy and the transition to cardiac decompensation in rats with chronic aortic banding. Circ Res 1993;73:184–192.

    Google Scholar 

  9. Izumo S, Lompre AM, Matsuoka R, Koren G, Schwartz K, Nadal-Ginard B, Mahdavi V. Myosin heavy chain messenger RNA and protein isoform transitions during cardiac hypertrophy: interaction between hemodynamic and thyroid hormone-induced signals. J Clin Invest 1987;79:970–977.

    Google Scholar 

  10. Charlemagne D, Maixent JM, Preteseille M, LeLievre LG. Ouabain binding sites and (Na+,K+)-ATPase activity in rat cardiac hypertrophy. Expression of the neonatal forms. J Biol Chem 1986;261:185–189.

    Google Scholar 

  11. Kelly DP, Strauss AW. Inherited cardiomyopathies. N Engl J Med 1994;330:913–919.

    Google Scholar 

  12. Bishop SP, Altschuld RA. Increased glycolytic metabolism in cardiac hypertrophy and congestive failure. Am J Physiol 1970;218:153–159.

    Google Scholar 

  13. Taegtmeyer H, Overturf ML. Effects of moderate hypertension on cardiac function and metabolism in the rabbit. Hypertension 1988;11:416–426.

    Google Scholar 

  14. Takeyama D, Kagaya Y, Yamane Y, Shiba N, Chida M, Takahashi T, Ido T, Ishide N, Takishima T. Effects of chronic right ventricular pressure overload on myocardial glucose and free fatty acid metabolism in the conscious rat. Cardiovasc Res 1995;29:763–767.

    Google Scholar 

  15. Massie BM, Schaefer S, Garcia J, McKirnan MD, Schwartz GG, Wisneski JA, Weiner MW, White FC. Myocardial high-energy phosphate and substrate metabolism in swine with moderate left ventricular hypertrophy. Circulation 1995;91:1814–1823.

    Google Scholar 

  16. Christe MD, Rodgers RL. Altered glucose and fatty acid oxidation in hearts of the spontaneously hypertensive rat. J Mol Cell Cardiol 1994;26:1371–1375.

    Google Scholar 

  17. Wittels B, Spann JF, Jr. Defective lipid metabolism in the failing heart. J Clin Invest 1968;47:1787–1794.

    Google Scholar 

  18. Bing RJ. The metabolism of the heart. Harvey Lect 1955;50:27–70.

    Google Scholar 

  19. Taegtmeyer H. Energy metabolism of the heart: from basic concepts to clinical applications. Curr Prob Cardiol 1994;19:57–116.

    Google Scholar 

  20. Wallace DC. Mitochondrial diseases in man and mouse. Science 1999;283:1482–1488.

    Google Scholar 

  21. Kelly DP, Gordon JI, Alpers R, Strauss AW. The tissue-specific expression and developmental regulation of the two nuclear genes encoding rat mitochondrial proteins: medium-chain acyl-CoA dehydrogenase and mitochondrial malate dehydrogenase. J Biol Chem 1989;264:18921–18925.

    Google Scholar 

  22. Brandt J, Djouadi F, Kelly DP. Fatty acids activate transcription of the muscle carnitine palmitoyltransferase I gene in cardiac myocytes via the peroxisome proliferator-activated receptor α. J Biol Chem 1998; 273:23786–23793.

    Google Scholar 

  23. Gulick T, Cresci S, Caira T, Moore DD, Kelly DP. The peroxisome proliferator activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression. Proc Natl Acad Sci USA 1994;91:11012–11016.

    Google Scholar 

  24. Djouadi F, Weinheimer C, Saffitz JE, Pitchford C, Bastin J, Gonzalez FJ, Kelly DP. A gender-related defect in lipid metabolism and glucose homeostasis in peroxisome proliferator-activated receptor α-deficient mice. J Clin Invest 1998;102:1083–1091.

    Google Scholar 

  25. Djouadi F, Brandt J, Weinheimer CJ, Leone TC, Gonzalez FJ, Kelly DP. The role of the peroxisome proliferator-activated receptor α (PPARα) in the control of cardiac lipid metabolism. Prostaglandins Leukot Essent Fatty Acids 1999;60:339–343.

    Google Scholar 

  26. Frohnert BI, Hui TY, Bernlohr DA. Identification of a functional peroxisome proliferator-responsive element in the murine fatty acid transport protein gene. J Biol Chem 1999;274:3970–3977.

    Google Scholar 

  27. Martin G, Poirier H, Hennuyer N, Crombie D, Fruchart JC, Heyman RA, Besnard P, Auwerx J. Induction of the fatty acid transport protein 1 and acyl-CoA synthase genes by dimer-selective rexinoids suggests that the peroxisome proliferator-activated receptor-retinoid X receptor heterodimer is their molecular target. J Biol Chem 2000;275:12612–12618.

    Google Scholar 

  28. Barger PM, Brandt JM, Leone TC, Weinheimer CJ, Kelly DP. Deactivation of peroxisome proliferator-activated receptor-α (PPARα) during cardiac hypertrophic growth. J Clin Invest 2000;105:1723–1730.

    Google Scholar 

  29. Sack MN, Rader TA, Park S, Bastin J, McCune SA, Kelly DP. Fatty acid oxidation enzyme gene expression is downregulated in the failing heart. Circulation 1996;94:2837–2842.

    Google Scholar 

  30. Rockman HA, Ono S, Ross RS, Jones LR, Karimi M, Bhargava V, Ross JJ, Chien KR. Molecular and physiological alterations in murine ventricular dysfunction. Proc Natl Acad Sci USA 1994;91:2694–2698.

    Google Scholar 

  31. Sack MN, Disch DL, Rockman HA, Kelly DP. A role for Sp and nuclear receptor transcription factors in a cardiac hypertrophic growth program. Proc Natl Acad Sci USA 1997;94:6438–6443.

    Google Scholar 

  32. Disch DL, Rader TA, Cresci S, Leone TC, Barger PM, Vega R, Wood PA, Kelly DP. Transcriptional control of a nuclear gene encoding a mitochondrial fatty acid oxidation enzyme in transgenic mice: role for nuclear receptors in cardiac and brown adipose expression. Mol Cell Biol 1996;16:4043–4051.

    Google Scholar 

  33. Carter ME, Gulick T, Moore DD, Kelly DP. A pleiotropic element in the medium-chain acyl coenzyme A dehydrogenase gene promoter mediates transcriptional regulation by multiple nuclear receptor transcription factors and defines novel receptor-DNA binding motifs. Mol Cell Biol 1994;14:4360–4372.

    Google Scholar 

  34. Puigserver P, Wu Z, Park CW, Graves R, Wright M, Spiegelman BM. A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis. Cell 1998;92:829–839.

    Google Scholar 

  35. Vega RB, Huss JM, Kelly DP. The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor a in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol Cell Biol 2000;20:1868–1876.

    Google Scholar 

  36. Wu Z, Puigserver P, Andersson U, Zhang C, Adelmant G, Mootha V, Troy A, Cinti S, Lowell B, Scarpulla RC, Spiegelman BM. Mechanisms controlling mitochondrial biogenesis and respiration through the thermogenic coactivator PGC-1. Cell 1999;98:115–124.

    Google Scholar 

  37. Puigserver P, Adelmant G, Wu Z, Fan M, Xu J, O'Malley B, Spiegelman BM. Activation of PPARγ coactivator-1 through transcription factor docking. Science 1999;286:1368–1371.

    Google Scholar 

  38. Frohlich ED, Apstein C, Chobanian AV, Devereux RB, Dustan HP, Dzau V, Fauad-Tarazi F, Horan MJ, Marcus M, Massie B, Pfeffer MA, Re RN, Roccella EJ, Savage D, Shub C. The heart in hypertension. N Engl J Med 1992;327:998–1008.

    Google Scholar 

  39. Leone TC, Weinheimer CJ, Kelly DP. A critical role for the peroxisome proliferator-activated receptor 184 Lehman and Kelly alpha (PPARα) in the cellular fasting response: The PPARα-null mouse as a model of fatty acid oxidation disorders. Proc Natl Acad Sci USA 1999;96: 7473–7478.

    Google Scholar 

  40. Greaves P, Martin J, Michel MC, Mompon P. Cardiac hypertrophy in the dog and rat induced by oxfenicine, an agent which modifies muscle metabolism. Arch Toxicol 1984;7:488–493.

    Google Scholar 

  41. Rupp H, Jacob R. Metabolically-modulated growth and phenotype of the rat. Eur Heart J 1992;13:56–61.

    Google Scholar 

  42. Abel ED, Kaulbach HC, Tian R, Hopkins JCA, Duffy J, Doetschman T, Minnemann T, Boers ME, Hadro E, Oberste-Berghaus C, Quist W, Lowell BB, Ingwall JS, Kahn BB. Cardiac hypertrophy with preserved contractile function after selective deletion of GLUT4 from the heart. J Clin Invest 1999;104:1703–1714.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Cardiovascular Research, Departments of Medicine and Molecular Biology & Pharmacology, Washington University School of Medicine, St. Louis, Missouri

    John J. Lehman MD & Daniel P. Kelly MD

Authors
  1. John J. Lehman MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniel P. Kelly MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lehman, J.J., Kelly, D.P. Gene Regulatory Mechanisms Governing Energy Metabolism during Cardiac Hypertrophic Growth. Heart Fail Rev 7, 175–185 (2002). https://doi.org/10.1023/A:1015332726303

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1015332726303

Search

Navigation